Overview
No overview information available.
Indication
用于不能切除的局部晚期或转移性胃癌。 用于治疗成人胆道癌【日本PMDA已批准；《胆管癌诊断与治疗-外科专家共识》】。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/26 | Phase 2 | Recruiting | |||
2025/06/18 | Phase 1 | Recruiting | |||
2025/06/12 | Phase 2 | Not yet recruiting | zhoujing | ||
2025/04/06 | Phase 2 | Not yet recruiting | |||
2025/03/25 | Phase 4 | Not yet recruiting | |||
2025/03/18 | Phase 2 | Not yet recruiting | |||
2024/12/13 | Phase 1 | Recruiting | |||
2024/12/12 | Phase 2 | Recruiting | |||
2024/10/24 | Phase 2 | Recruiting | Sun Yat-sen University | ||
2024/09/19 | Phase 2 | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字HJ20130816 | 化学药品 | 胶囊剂 | 8/24/2023 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20100135 | 化学药品 | 胶囊剂 | 7/23/2020 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20080803 | 化学药品 | 胶囊剂 | 4/17/2023 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字HJ20130812 | 化学药品 | 胶囊剂 | 8/24/2023 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20100151 | 化学药品 | 胶囊剂 | 4/29/2020 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字HJ20130817 | 化学药品 | 胶囊剂 | 8/24/2023 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20243202 | 化学药品 | 胶囊剂 | 2/23/2024 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字HJ20130811 | 化学药品 | 胶囊剂 | 8/24/2023 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20243203 | 化学药品 | 胶囊剂 | 2/23/2024 | |
| Tegafur Gimeracil Oteracil Potassium Capsule | 国药准字H20100150 | 化学药品 | 胶囊剂 | 4/29/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.